Dialysis

The National Kidney Foundation Statement on Centers for Medicare and Medicaid Services Rule Requiring Vaccinations for Dialysis Facility Staff

Retrieved on: 
Thursday, November 4, 2021
People, Population, Volunteering, Dialysis, National Kidney Foundation, CKD, CMS, Medicare, Student, Kidney, Degenerative disease, CEO, Disease, NKF, Centers for Medicare & Medicaid Services, COVID-19, Chronic kidney disease, White, Kidney disease, Transplant, Awareness, Center, Risk factor, Diabetes, Vaccination, Patient, Risk, Kidney failure, Obesity, Pharmaceutical industry

NEW YORK, Nov. 4, 2021 /PRNewswire/ -- Today, the National Kidney Foundation (NKF), the leading kidney patient organization in the U.S., applauds the Centers for Medicare and Medicaid Services (CMS) for protecting dialysis patients.

Key Points: 
  • NEW YORK, Nov. 4, 2021 /PRNewswire/ -- Today, the National Kidney Foundation (NKF), the leading kidney patient organization in the U.S., applauds the Centers for Medicare and Medicaid Services (CMS) for protecting dialysis patients.
  • "It's important to remember that the first person in the U.S. who died from COVID-19 was a dialysis patient," said Kevin Longino, CEO of National Kidney Foundation and a kidney transplant patient.
  • We also encourage all kidney patients and their care partners, family members and loved ones to get vaccinated ," added Longino.
  • Approximately 785,000 Americans have irreversible kidney failure and need dialysis or a kidney transplant to survive.

The National Kidney Foundation Presents Innovative NKF Patient Network to Nephrology Community

Retrieved on: 
Thursday, November 4, 2021
People, Society, Obesity, American Society of Nephrology, Health care, CKD, MD, Division, Education, Degenerative disease, Disease, Doctor of Philosophy, NKF, Blood, Senior, Bayer, Research, Chronic kidney disease, National Kidney Foundation, White, Network, Dialysis, Database, Kidney disease, Patient, Awareness, Kidney, Data, Risk factor, Review, ASN, Diabetes, Risk, Kidney failure, Tufts Medical Center, Medicine, Pharmaceutical industry

NEW YORK, Nov. 4, 2021 /PRNewswire/ -- The National Kidney Foundation (NKF) will present today the new NKF Patient Network to nephrologists and other kidney care professionals during the virtual poster presentations at the American Society of Nephrology (ASN) 54th Annual Meeting & Scientific Exposition.

Key Points: 
  • NEW YORK, Nov. 4, 2021 /PRNewswire/ -- The National Kidney Foundation (NKF) will present today the new NKF Patient Network to nephrologists and other kidney care professionals during the virtual poster presentations at the American Society of Nephrology (ASN) 54th Annual Meeting & Scientific Exposition.
  • Lesley Inker, MD, Division of Nephrology, Tufts Medical Center, Boston, and NKF's Senior Director Patient Outcomes Research, Silvia Ferr PhD, will present the information about the NKF Patient Network.
  • The Network welcomes people with all stages and types of kidney disease, including dialysis and kidney transplant recipients.
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .

The National Kidney Foundation to Doctors: Listen to Complaints of Itchy Skin

Retrieved on: 
Thursday, November 4, 2021
Linda, People, Uremic pruritus, Quality of life, Society, Obesity, American Society of Nephrology, National Kidney Foundation, Health care, Mount Sinai, Icahn School of Medicine at Mount Sinai, CKD, MD, Itch, Degenerative disease, Disease, NKF, Radar, Chronic kidney disease, White, Dialysis, Kidney disease, Patient, Itchy, Awareness, Hospital, Science, Risk factor, Death, ASN, Diabetes, Skin, Risk, Kidney failure, Medical device, Medicine, Tutoring, Pharmaceutical industry

This survey cohort of hemodialysis patients report near universal experience of itchy skin, with one in four characterizing their itch as "very" or "extremely intense."

Key Points: 
  • This survey cohort of hemodialysis patients report near universal experience of itchy skin, with one in four characterizing their itch as "very" or "extremely intense."
  • In the United States, 37 million adults are estimated to have kidney disease , also known as chronic kidney disease (CKD)and approximately 90 percent don't know they have it.
  • 1 in 3 adults in the U.S. are at risk for kidney disease.Risk factors for kidney disease include: diabetes , high blood pressure , heart disease , obesity , and family history.
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .

Associates of Cape Cod Inc. Announces the Release of its One Millionth Horseshoe Crab From its Species Sustainability Project

Retrieved on: 
Thursday, November 4, 2021
Safety, Research, ACC, Biotechnology, Technology, Aquaculture, Industry, Quality control, FDA, Horseshoe, Achievement, Dialysis, U.S. FDA, CEO, Tachypleus, BET, Growth, Environment, Biodiversity, Program, Egg, Printing, Culture, Association of Chiropractic Colleges, LAL, Associate

E. FALMOUTH, Mass., Nov. 4, 2021 /PRNewswire/ --ACC proudly announces that it has achieved the release of its millionth juvenile horseshoe crab to the wild, as a result of its species sustainability project.

Key Points: 
  • E. FALMOUTH, Mass., Nov. 4, 2021 /PRNewswire/ --ACC proudly announces that it has achieved the release of its millionth juvenile horseshoe crab to the wild, as a result of its species sustainability project.
  • ACC's reagents are used worldwide in pharmaceutical, medical device, biotechnology, compounding pharmacy and dialysis industries for quality control, product release and research.
  • Unique first of its kind sustainability program rears and releases its millionth juvenile horseshoe crab to the wild.
  • "Our horseshoe crab sustainability project is important to the company and other stakeholders of effected ecosystems", noted Dr. A.J.

Associates of Cape Cod Inc. Announces the Release of its One Millionth Horseshoe Crab From its Species Sustainability Project

Retrieved on: 
Thursday, November 4, 2021
Safety, Research, ACC, Biotechnology, Technology, Aquaculture, Industry, Quality control, FDA, Horseshoe, Achievement, Dialysis, U.S. FDA, CEO, Tachypleus, BET, Growth, Environment, Biodiversity, Program, Egg, Printing, Culture, Association of Chiropractic Colleges, LAL, Associate

E. FALMOUTH, Mass., Nov. 4, 2021 /PRNewswire/ --ACC proudly announces that it has achieved the release of its millionth juvenile horseshoe crab to the wild, as a result of its species sustainability project.

Key Points: 
  • E. FALMOUTH, Mass., Nov. 4, 2021 /PRNewswire/ --ACC proudly announces that it has achieved the release of its millionth juvenile horseshoe crab to the wild, as a result of its species sustainability project.
  • ACC's reagents are used worldwide in pharmaceutical, medical device, biotechnology, compounding pharmacy and dialysis industries for quality control, product release and research.
  • With the goal of maintaining the greatest biodiversity possible, ACC's species sustainability project sources NAHSC eggs and gametes exclusively from crabs destined for terminal use as bait by the fishing industry.
  • "Our horseshoe crab sustainability project is important to the company and other stakeholders of effected ecosystems", noted Dr. A.J.

ZOLL TherOx SuperSaturated Oxygen Therapy to Be Highlighted at TCT Scientific Symposium

Retrieved on: 
Thursday, November 4, 2021
Software, Research, Other Health, General Health, Pharmaceutical, Technology, Medical Devices, Science, Cardiology, Biotechnology, Other Technology, Health, Other Science, Beaumont Hospital, Angioplasty, LAD, STEMI, Percutaneous coronary intervention, Ventilation, EMS, TCT, Patient, Level 1, Data management, FDA, Hamad Medical Corporation, Supersaturation, Oxygen, CPR, Dialysis, Widow, Life, MI, Asahi Kasei, Muscle tissue, Solution, Moderation, Mortality, Temperature, Health care, Ammonia, Medical device, Pharmaceutical industry, 3D printing, ZOLL, Asahi Kasei, ZOLL, ASAHI KASEI

ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that its TherOx SuperSaturated Oxygen (SSO2) Therapy will be highlighted at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) annual scientific meeting November 4-6 in Orlando, Florida.

Key Points: 
  • ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that its TherOx SuperSaturated Oxygen (SSO2) Therapy will be highlighted at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) annual scientific meeting November 4-6 in Orlando, Florida.
  • ZOLL TherOx will host product demonstrations and discussions with thought leaders who will share their real-world experiences with SSO2 Therapy in technology suite #CS 5.
  • Our participation in and support of TCT is an essential part of expanding the frontier of STEMI care with SSO2 Therapy, said Neil Johnston, President of ZOLL Circulation.
  • SuperSaturated Oxygen (SSO2) Therapy is the first and only FDA-approved treatment shown to significantly reduce myocardial damage in heart attack patients after percutaneous coronary intervention.

Research Presented by Fresenius Medical Care North America at Kidney Week 2021 Demonstrates Commitment to Improving Dialysis Care

Retrieved on: 
Thursday, November 4, 2021
Research, 2021 Essex County Council election, Nephrology, American Society of Nephrology, PD, Fresenius Medical Care, Patient, ASN, Severe acute respiratory syndrome coronavirus 2, Dialysis, Risk, Intelligence, HD, Kidney, Maintenance, Disease, COVID-19, GI, Peritoneal dialysis, Initiative, Publication, Mortality, Hospital, Association, INSPIRE, Smartphone, Society, Kidney failure, Pharmaceutical industry, Medical device

WALTHAM, Mass., Nov. 4, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, today announced the presentation of 40 company-affiliated abstracts at the American Society of Nephrology's (ASN) Kidney Week 2021 ,which runs virtually from Nov. 4-7.

Key Points: 
  • WALTHAM, Mass., Nov. 4, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, today announced the presentation of 40 company-affiliated abstracts at the American Society of Nephrology's (ASN) Kidney Week 2021 ,which runs virtually from Nov. 4-7.
  • "The depth of scientific works presented demonstrates our ongoing commitment across the company to generate new insights that can improve care delivery and patient outcomes," said Dr. Robert Kossmann, Chief Medical Officer for FMCNA.
  • Some of the other abstracts being presented by Fresenius Medical Care, and now available online as part of ASN's Kidney Week 2021, include:
    Machine Learning-Driven Prediction of Peritoneal Dialysis Technique Failure .
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.

University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500 Community Practices

Retrieved on: 
Thursday, November 4, 2021
Nephrology, SAN, University, Emergency, Organization, Caregiver, Patient, Social, SEC, Dialysis, Communication, Senior, Precision medicine, UAB, Annual report, MIT Center for Digital Business, Documentation, Integration, University of Alabama, GLOBE, A Call for Unity, Dentistry

The intake process can be an onerous process, requiring documentation from various medical professionals who are often not in an integrated network.

Key Points: 
  • The intake process can be an onerous process, requiring documentation from various medical professionals who are often not in an integrated network.
  • TxAccess allows transplant centers to have a streamlined communication to nephrologists and dialysis organizations.
  • To date, over 38,000 referrals have been managed with TxAccess as a growing number of transplant centers adopt the service.
  • CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

Outset Medical to Present at Stifel 2021 Virtual Health Care Conference

Retrieved on: 
Tuesday, November 2, 2021
Medical Devices, Health, Dialysis, Water purification, Medicine, Patient, Technology, Conference, FDA, View, Medical device

Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the Stifel 2021 Virtual Health Care Conference on Tuesday, November 16, 2021 at 1:40pm PT / 4:40pm ET.

Key Points: 
  • Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the Stifel 2021 Virtual Health Care Conference on Tuesday, November 16, 2021 at 1:40pm PT / 4:40pm ET.
  • Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.
  • Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.
  • Tablo is a registered trademark of Outset Medical, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005906/en/

Best Selling Authors Gather Virtually with Fans to Raise Awareness and Funds for Kidney Disease

Retrieved on: 
Tuesday, November 2, 2021
People, Book, Book and Author Luncheon, Degenerative disease, SAN, Annual, National Kidney Foundation, Disease, NPR, Obesity, NKF, Patient, Awkward Black Girl, Lincoln Highway, Dialysis, Risk, Chronic kidney disease, Silver, Kidney, CEO, Pulitzer Prize, COVID-19, Awareness, Kidney disease, Diabetes, CKD, Risk factor, White, Reading, Kidney failure, Pharmaceutical industry

"There are 37 million adults in the U.S. with kidney disease, yet 90% don't even know they have it," said Shelia Gordon, volunteer chair of the Authors Luncheon.

Key Points: 
  • "There are 37 million adults in the U.S. with kidney disease, yet 90% don't even know they have it," said Shelia Gordon, volunteer chair of the Authors Luncheon.
  • For information about the Authors Luncheon, visit kidney.org/authors or email [email protected]
    About Kidney Disease in the United States, 37 million adults are estimated to have kidney disease, also known as chronic kidney disease (CKD)and approximately 90 percent don't know they have it.
  • Risk factors for kidney disease include: diabetes, high blood pressure, heart disease, obesity, and family history.
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .